France's CNAM plans Rx database expansion

2 September 2007

France's national federation of sickness insurance funds (CNAM) has announced the go-ahead for a computer-based system that already allows 3,000 doctors to access a 12-month history of treatment, drug prescribing and reimbursement of their patients. The personal medical dossier (DMP) system has so far been been tested in four areas of the country.

When first conceived, in 2004, the DMP was regarded as a highly useful measure of health service reform but has since been held up by a series of reviews by the government's inspectorates. The CNAM now argues that the DMP should no longer be delayed and has now obtained approval to extend pilot schemes across the whole country.

Some aspects of the system such as the pharmaceutical dossier are becoming well established, notably in pharmacies. However, the CNAM wants to extend the computerized history of patient reimbursement across the country. This will allow doctors to obtain a history of prescribing and can be accessed both by doctors and patients by different smart cards. It will enable a rapid overview of drug prescribing when a patient is new to a practice and should reduce problems caused by incompatible prescribing. Patients who seek multiple consultations and examinations, which tends to generate over-prescribing will be discouraged.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight